Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · MXE

Is MXE legal in Trinidad and Tobago?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
No placement is asserted for MXE in Trinidad and Tobago on this record, and none should be read into it. What the dossier holds for this row is a search rather than an entry: the terms checked in the Dangerous Drugs Act, Chapter 11:25, First and Second Schedules, including Legal Notice No. 345 of 2019 were «metoxetamina (MXE)» together with the slug spelling «mxe», spelling variants and the chemical name, and no current named entry and no closed group rule was proved. The recorded search term is a Spanish language form while Chapter 11:25 is enacted in English, so the search is weaker than its wording suggests, and an English schedule word could exist that these terms would never have reached. The row was checked in its own right because it tests a methoxy arylcyclohexylamine without importing ketamine or PCP status. An unproved entry is a statement about this reading and not about the substance. It means the question was not settled here, and it is not a finding that the material is lawful to hold or to bring in.
Consequences if caught
Capital exposure: none. No limb of the Dangerous Drugs Act, Chapter 11:25, reaches death, so the capital answer does not depend on this row's placement and can be given even though the placement cannot. What placement would have set is the custodial ceiling, and that is exactly what this reading did not settle, so no ceiling is stated below. Trinidad and Tobago does retain capital punishment for murder, which is a different statute and a different offence, so a flat claim that the country has no death penalty would be wrong even where it is right about this Act. No ceiling is assigned on this row, because controlled status was not settled from the primary instrument and a penalty cannot be attached to a placement that was never proved. Sections 3 and 5 of Chapter 11:25 would be the operative provisions if the status were settled, and neither can be quoted against this row today. Nothing attaches to a street name. The exposure follows the identification, and what has to be identified here is a methoxylated arylcyclohexylamine, tested without importing the anaesthetic or the phencyclidine result. Do not read the open status as a reason to expect a lower tier. An officer works from the presentation in front of him and from the analysis that follows, and neither is bound by a record that failed to settle the question.
If prescribed or medical
The dossier records no traveller import scheme, no permit route and no prescription rule for Trinidad and Tobago, so this row defers on that branch rather than inventing one. The country level position that can honestly be stated is the general one: a foreign prescription is evidence about a patient, it is not a Trinidad and Tobago authorisation, and it does not become one at the border. Attached to this row, the placement itself is unsettled, so neither a permission nor a prohibition can be stated and a traveller cannot plan around either. It has never been a medicine, so there is no prescription route to defer on.
Documentation
Nothing documents it. It was sold as a lawful substitute for the anaesthetic, and a substitution claim made by a vendor is not a schedule position. The search recorded for this row, «metoxetamina (MXE)» together with the slug spelling, was run on 20 September 2026 across the same schedules and proved no entry, so nothing here rests on a placement. Whatever is carried, carry it in the container it was issued in, with the paper that names the patient, the substance, the dose and the period. A container separated from its label is the commonest way a lawful supply stops looking like one.
Primary sources
  • Trinidad and Tobago, Dangerous Drugs Act, Chapter 11:25, First and Second Schedules, read with Legal Notice No. 345 of 2019 and with sections 3 and 5, section 5 as amended by the Dangerous Drugs (Amendment) Act No. 24 of 2019
  • read as at 20 September 2026. The two real hyperlink targets held for the whole document are https://laws.gov.tt/ttdll-web/revision/download/46934?type=act and https://www.ttparliament.org/wp-content/uploads/2022/01/a2019-24g.pdf, and both are document level. This citation is document level and not per substance: the links column for this row holds the constructed text «mxe schedule | mxe penalty», which is a label and not a hyperlink, so no address in this field points at this row's entry rather than at the instrument as a whole. The row's own evidence is a search record over «metoxetamina (MXE)» and the slug spelling, which proved no entry and assigned no penalty article. One provenance caution belongs on this row. The term the dossier records is a Spanish language form while Chapter 11:25 is enacted in English, so the record's term and the instrument's language do not match, and the citation should be read with that mismatch in view. The line this reading had to hold for this row in particular is that it tests a methoxy arylcyclohexylamine without importing ketamine or PCP status.

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

MXE in related jurisdictions

Other substances confirmed in Trinidad and Tobago